000 | 01267 a2200349 4500 | ||
---|---|---|---|
005 | 20250515230121.0 | ||
264 | 0 | _c20101124 | |
008 | 201011s 0 0 eng d | ||
022 | _a1744-7623 | ||
024 | 7 |
_a10.1517/14728214.2010.497754 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFung, Christopher | |
245 | 0 | 0 |
_aEmerging drugs to treat squamous cell carcinomas of the head and neck. _h[electronic resource] |
260 |
_bExpert opinion on emerging drugs _cSep 2010 |
||
300 |
_a355-73 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPrecision Medicine _xmethods |
700 | 1 | _aGrandis, Jennifer R | |
773 | 0 |
_tExpert opinion on emerging drugs _gvol. 15 _gno. 3 _gp. 355-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728214.2010.497754 _zAvailable from publisher's website |
999 |
_c19906288 _d19906288 |